Tannous, Maria
Tannous, Maria
CHIMICA
Current Status and Trends in Nucleic Acids for Cancer Therapy: A Focus on Polysaccharide-Based Nanomedicines
2023-01-01 Molinar, Chiara; Tannous, Maria; Meloni, Domitilla; Cavalli, Roberta; Scomparin, Anna
Cyclic nigerosyl-1,6-nigerose-based nanosponges: An innovative pH and time-controlled nanocarrier for improving cancer treatment
2018-01-01 Caldera, F.; Argenziano, M.; Trotta, F.; Dianzani, C.; Gigliotti, L.; Tannous, M.; Pastero, L.; Aquilano, D.; Nishimoto, T.; Higashiyama, T.; Cavalli, R.*
Dextrin-Based Nanohydrogels for Rokitamycin Prolonged Topical Delivery
2022-01-01 Tannous, Maria; Lucia Appleton, Silvia; Hoti, Gjylije; Caldera, Fabrizio; Argenziano, Monica; Monfared, Yousef Khazaei; Matencio, Adrián; Trotta, Francesco; Cavalli, Roberta
Drug-Encapsulated Cyclodextrin Nanosponges
2021-01-01 Tannous M.; Caldera F.; Hoti G.; Dianzani U.; Cavalli R.; Trotta F.
Evolution of Cyclodextrin Nanosponges
2017-01-01 Caldera, Fabrizio*; Tannous, Maria; Cavalli, Roberta; Zanetti, Marco; Trotta, Francesco
History of cyclodextrin nanosponges
2020-01-01 Krabicova I.; Appleton S.L.; Tannous M.; Hoti G.; Caldera F.; Pedrazzo A.R.; Cecone C.; Cavalli R.; Trotta F.
Nanosponges as protein delivery systems: Insulin, a case study
2020-01-01 Appleton S.L.; Tannous M.; Argenziano M.; Muntoni E.; Rosa A.C.; Rossi D.; Caldera F.; Scomparin A.; Trotta F.; Cavalli R.
Nanosponges for combination drug therapy: State-of-the-art and future directions
2020-01-01 Tannous M.; Trotta F.; Cavalli R.
Oxygen Nanocarriers for Improving Cardioplegic Solution Performance: Physico-Chemical Characterization
2023-01-01 Tannous M.; Hoti G.; Trotta F.; Cavalli R.; Higashiyama T.; Pagliaro P.; Penna C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Current Status and Trends in Nucleic Acids for Cancer Therapy: A Focus on Polysaccharide-Based Nanomedicines | 2023 | Molinar, Chiara; Tannous, Maria; Meloni, Domitilla; Cavalli, Roberta; Scomparin, Anna | |
| Cyclic nigerosyl-1,6-nigerose-based nanosponges: An innovative pH and time-controlled nanocarrier for improving cancer treatment | 2018 | Caldera, F.; Argenziano, M.; Trotta, F.; Dianzani, C.; Gigliotti, L.; Tannous, M.; Pastero, L.; Aquilano, D.; Nishimoto, T.; Higashiyama, T.; Cavalli, R.* | |
| Dextrin-Based Nanohydrogels for Rokitamycin Prolonged Topical Delivery | 2022 | Tannous, Maria; Lucia Appleton, Silvia; Hoti, Gjylije; Caldera, Fabrizio; Argenziano, Monica; Monfared, Yousef Khazaei; Matencio, Adrián; Trotta, Francesco; Cavalli, Roberta | |
| Drug-Encapsulated Cyclodextrin Nanosponges | 2021 | Tannous M.; Caldera F.; Hoti G.; Dianzani U.; Cavalli R.; Trotta F. | |
| Evolution of Cyclodextrin Nanosponges | 2017 | Caldera, Fabrizio*; Tannous, Maria; Cavalli, Roberta; Zanetti, Marco; Trotta, Francesco | |
| History of cyclodextrin nanosponges | 2020 | Krabicova I.; Appleton S.L.; Tannous M.; Hoti G.; Caldera F.; Pedrazzo A.R.; Cecone C.; Cavalli R.; Trotta F. | |
| Nanosponges as protein delivery systems: Insulin, a case study | 2020 | Appleton S.L.; Tannous M.; Argenziano M.; Muntoni E.; Rosa A.C.; Rossi D.; Caldera F.; Scomparin A.; Trotta F.; Cavalli R. | |
| Nanosponges for combination drug therapy: State-of-the-art and future directions | 2020 | Tannous M.; Trotta F.; Cavalli R. | |
| Oxygen Nanocarriers for Improving Cardioplegic Solution Performance: Physico-Chemical Characterization | 2023 | Tannous M.; Hoti G.; Trotta F.; Cavalli R.; Higashiyama T.; Pagliaro P.; Penna C. |